Literature DB >> 17545188

Adaptation of HIV-1 to its human host.

Louise V Wain1, Elizabeth Bailes, Frederic Bibollet-Ruche, Julie M Decker, Brandon F Keele, Fran Van Heuverswyn, Yingying Li, Jun Takehisa, Eitel Mpoudi Ngole, George M Shaw, Martine Peeters, Beatrice H Hahn, Paul M Sharp.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) originated from three independent cross-species transmissions of simian immunodeficiency virus (SIVcpzPtt) infecting chimpanzees (Pan troglodytes troglodytes) in west central Africa, giving rise to pandemic (group M) and non-pandemic (groups N and O) clades of HIV-1. To identify host-specific adaptations in HIV-1 we compared the inferred ancestral sequences of HIV-1 groups M, N and O to 12 full length genome sequences of SIVcpzPtt and four of the outlying but closely related SIVcpzPts (from P. t. schweinfurthii). This analysis revealed a single site that was completely conserved among SIVcpzPtt strains but different (due to the same change) in all three groups of HIV-1. This site, Gag-30, lies within p17, the gag-encoded matrix protein. It is Met in SIVcpzPtt, underwent a conservative replacement by Leu in one lineage of SIVcpzPts but changed radically to Arg on all three lineages leading to HIV-1. During subsequent diversification this site has been conserved as a basic residue (Arg or Lys) in most lineages of HIV-1. Retrospective analysis revealed that Gag-30 had reverted to Met in a previous experiment in which HIV-1 was passaged through chimpanzees. To examine whether this substitution conferred a species specific growth advantage, we used site-directed mutagenesis to generate variants of these chimpanzee-adapted HIV-1 strains with Lys at Gag-30, and tested their replication in both human and chimpanzee CD4+ T lymphocytes. Remarkably, viruses encoding Met replicated to higher titers than viruses encoding Lys in chimpanzee T cells, but the opposite was found in human T cells. Taken together, these observations provide compelling evidence for host-specific adaptation during the emergence of HIV-1 and identify the viral matrix protein as a modulator of viral fitness following transmission to the new human host.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545188      PMCID: PMC4053193          DOI: 10.1093/molbev/msm110

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  39 in total

1.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

2.  Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

Authors:  C A Derdeyn; J M Decker; J N Sfakianos; X Wu; W A O'Brien; L Ratner; J C Kappes; G M Shaw; E Hunter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  The rapid generation of mutation data matrices from protein sequences.

Authors:  D T Jones; W R Taylor; J M Thornton
Journal:  Comput Appl Biosci       Date:  1992-06

Review 4.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

Review 5.  The origins of acquired immune deficiency syndrome viruses: where and when?

Authors:  P M Sharp; E Bailes; R R Chaudhuri; C M Rodenburg; M O Santiago; B H Hahn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-06-29       Impact factor: 6.237

6.  Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods.

Authors:  Z Yang
Journal:  J Mol Evol       Date:  1994-09       Impact factor: 2.395

7.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

8.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Near full-length genomes of 15 HIV type 1 group O isolates.

Authors:  Julie Yamaguchi; Pierre Bodelle; Lazare Kaptué; Leopold Zekeng; Lutz G Gürtler; Sushil G Devare; Catherine A Brennan
Journal:  AIDS Res Hum Retroviruses       Date:  2003-11       Impact factor: 2.205

10.  Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

Authors:  Sarah C Ball; Awet Abraha; Kalonji R Collins; Andre J Marozsan; Heather Baird; Miguel E Quiñones-Mateu; Adam Penn-Nicholson; Michael Murray; Nathalie Richard; Michael Lobritz; Peter A Zimmerman; Tatsuyoshi Kawamura; Andrew Blauvelt; Eric J Arts
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  55 in total

1.  International multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasma.

Authors:  Claire Ham; Priya Srinivasan; Rigmor Thorstensson; Ernst Verschoor; Zahra Fagrouche; Leonardo Sernicola; Artur Ramos; Fausto Titti; Neil Almond; Neil Berry
Journal:  J Clin Microbiol       Date:  2010-04-28       Impact factor: 5.948

2.  The evolution of HIV-1 and the origin of AIDS.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-08-27       Impact factor: 6.237

3.  Recent host-shifts in ranaviruses: signatures of positive selection in the viral genome.

Authors:  A Jeanine Abrams; David C Cannatella; David M Hillis; Sara L Sawyer
Journal:  J Gen Virol       Date:  2013-06-19       Impact factor: 3.891

4.  A new human immunodeficiency virus derived from gorillas.

Authors:  Jean-Christophe Plantier; Marie Leoz; Jonathan E Dickerson; Fabienne De Oliveira; François Cordonnier; Véronique Lemée; Florence Damond; David L Robertson; François Simon
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

Review 5.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

6.  Positive selection on HIV accessory proteins and the analysis of molecular adaptation after interspecies transmission.

Authors:  André E R Soares; Marcelo A Soares; Carlos G Schrago
Journal:  J Mol Evol       Date:  2008-05-09       Impact factor: 2.395

7.  Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Authors:  Kei Sato; Naoko Misawa; Junko S Takeuchi; Tomoko Kobayashi; Taisuke Izumi; Hirofumi Aso; Shumpei Nagaoka; Keisuke Yamamoto; Izumi Kimura; Yoriyuki Konno; Yusuke Nakano; Yoshio Koyanagi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

8.  Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

Authors:  Jun Takehisa; Matthias H Kraus; Ahidjo Ayouba; Elizabeth Bailes; Fran Van Heuverswyn; Julie M Decker; Yingying Li; Rebecca S Rudicell; Gerald H Learn; Cecile Neel; Eitel Mpoudi Ngole; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 9.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

10.  Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission.

Authors:  Nobubelo K Ngandu; Cathal Seoighe; Konrad Scheffler
Journal:  Virol J       Date:  2009-10-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.